<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0115">
 <label>23</label>
 <element-citation publication-type="journal" id="rf0115">
  <person-group person-group-type="author">
   <name>
    <surname>Casillo</surname>
    <given-names>G.M.</given-names>
   </name>
   <name>
    <surname>Mansour</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Raucci</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Saviano</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Mascolo</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Jilani Iqbal</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?</article-title>
  <source>Pharmacol. Res.</source>
  <year>2020</year>
  <fpage>104791</fpage>
  <pub-id pub-id-type="pmid">32302707</pub-id>
 </element-citation>
</ref>
